WW International

• NCT05176626

  Collaborator, Phase 4, Active, not recruiting, 870 people, 4 Jan 2022

• Avoid and Resist Strategies for Weight Management

  Collaborator, Active, not recruiting, 503 people, 3 Dec 2021

Sources: clinicaltrials.gov

• Design and baseline characteristics of the CagriSema cardiovascular outcomes trial (REDEFINE 3)

  Consulting or advice, 6 Oct 2026

• Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial

  Grants or research support, 11 Jan 2022

• Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial

  Consulting or advice, Fees or honoraria, Grants or research support, Board or leadership role, 13 Apr 2021

Sources: pubmed.ncbi.nlm.nih.gov

• Relationship between BMI and Glucose Metrics in CGM Users in App-Enabled Weight Loss Program

  ADA Scientific Sessions 2026 abstract, 6 Jun 2026